Cmpx stock forecast.

Based on short-term price targets offered by seven analysts, the average price target for Compass Therapeutics, Inc. comes to $9.33. The forecasts range from a low of $8.00 to a high of $11.00 ...Get NASDAQ Composite Index (.IXIC) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsTrack COMPASS Pathways (CMPS) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors The average Compass Therapeutics stock price prediction forecasts a potential upside of 528.93% from the current CMPX share price of $1.59. What is CMPX's forecast return on assets (ROA) for 2023-2026?

March 7, 2024. EPS forecast (this quarter) $0.30. Annual revenue (last year) $378.5M. Annual profit (last year) $18.7M. Net profit margin.

Nov 10, 2023 · Website. 2014. 26. Tom Schuetz. https://www.compasstherapeutics.com. Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company’s product candidates include CTX-009, a bispecific antibody that blocks Delta-like ligand 4 ... The above table shows the analyst CMPX forecast and predictions for the stock price in 12 month’s time. Date Share Price Average 1Y Price Target Dispersion High Low 1Y Actual price Analysts; Current: US$1.77

CMPX Stock Predictions. CMPX Stock Buy or Sell? - Get a free CMPX stock trend analysis report to help you analyze and make a better CMPX stock predictions. The stock analysis service is provided by MarketClub, using their Smart Scan and Trade Triangle technology. It uses technical analysis and the current market condition to give you the best ... In many cases to predict stock price, gold and crude oil have been used as extra indicators [36], in some of the works, 43 technical indicators as input features along with LSTM to forecast price ...Compass Therapeutics, Inc. (CMPX) NasdaqCM - NasdaqCM Real Time Price. Currency in USD Follow 2W 10W 9M 1.6500 -0.0700 (-4.07%) At close: 04:00PM EST 1.6500 0.00 (0.00%) After hours: 04:20PM EST...The Compass Therapeutics, Inc. stock price gained 2.42% on the last trading day (Friday, 1st Dec 2023), rising from $1.65 to $1.69. During the last trading …

Compass Therapeutics. Compass Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is developing proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. Its pipeline product candidates are CTX-471/ CD137 agonist and CTX-8371.

Compass Therapeutics, Inc. Common Stock (CMPX) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets.

CMPX Stock Forecast Chart 2w 1m 3m 9m 1y 1.3 1.4 1.5 1.6 1.7 1.8 1.9 2 Actual Price Upper Predicted Price Predicted Price Lower Predicted Price CMPX Stock Price …Stock analysis for CompX International Inc (CIX:NYSEAmerican) including stock price, stock chart, company news, key statistics, fundamentals and company profile.The Meme Stock. C-Suite Advisors. Sign In. ... Nvidia earnings crush forecasts, outlook tops estimates, amid surging AI demand. By Martin Baccardax. Nov 21, 2023 5:00 PM EST. STOCKS. MSFT NVDA.Leader in personal finance news and business forecasting. Get trusted advice on investing, retirement, taxes, saving, real estate, cars, college, insurance.Introducing Nasdaq Data Link - The Next Evolution in Data. The right insights, data and technology can create limitless possibilities. Nasdaq Data Link is a powerful, centralized, cloud-based ...Nov 15, 2023 · The projected low price target is $8.00 while the price target rests at a high of $11.00. In that case, then, we find that the current price level is -618.95% off the targeted high while a plunge would see the stock gain -422.88% from current levels. Compass Therapeutics Inc (CMPX) estimates and forecasts Data Link's cloud-based technology platform allows you to search, discover and access data and analytics for seamless integration via cloud APIs. Register for your free account today at data ...

AT&T stock has slumped in 2023, and director Stephen J. Luczo recently bought a large block of shares of the media and telecom firm. AT&T stock (ticker: T) has dropped about 12% this year, while ...See Compass Therapeutics, Inc. (CMPX) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest of the work.Nov 18, 2023 · It follows that stock’s current price would drop -591.82% in reaching the projected high whereas dropping to the targeted low would mean a loss of -403.14% for stock’s current value. Compass Therapeutics Inc (CMPX) estimates and forecasts CompX International, Inc. engages in the manufacturer of security products used in the recreational transportation, postal, office and institutional furniture, cabinetry, tool stoCompass Therapeutics, Inc. - Hold. Zacks' proprietary data indicates that Compass Therapeutics, Inc. is currently rated as a Zacks Rank 3 and we are expecting an inline return from the CMPX shares ...Nov 7, 2023 · Total Valuation. CMPX has a market cap or net worth of $224.33 million. The enterprise value is $55.37 million. Market Cap. 224.33M. Enterprise Value. 55.37M.

Most recent stock forecast was given on BGNE, BeiGene, Ltd at 26-Jun-2023 ... CMPX GLUE TNGX TPTX Turning Point Therapeutics NRIX Nurix Therapeutics COGT ...Find the latest Fusion Pharmaceuticals Inc. (FUSN) stock quote, history, news and other vital information to help you with your stock trading and investing.

Nov 10, 2023 · Website. 2014. 26. Tom Schuetz. https://www.compasstherapeutics.com. Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company’s product candidates include CTX-009, a bispecific antibody that blocks Delta-like ligand 4 ... Track Compass Therapeutics Inc (CMPX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsFord pegged the cost of the six-week UAW strikes at $1.7 billion, more than rival GM's $1.1 billion estimate, while issuing an updated 2023 profit forecast. STOCKS CRMCompass Therapeutics Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time CMPX stock price.Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools. Identify stocks that meet your criteria using seven unique stock screeners.F5 Inc. -0.42%. $9.16B. CALX | Complete Calix Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.We've seen plenty of personal finance tools designed to help you track what you're spending, but web site PocketSmith is an impressive new web-based personal finance tool with an emphasis on forecasting your financial future. We've seen ple...Find the latest Compass Therapeutics, Inc. CMPX analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.Total Valuation. CMPX has a market cap or net worth of $224.33 million. The enterprise value is $55.37 million. Market Cap. 224.33M. Enterprise Value. 55.37M.

CMPX Overview Stock Screener Earnings Calendar Sectors Nasdaq | CMPX U.S.: Nasdaq Compass Therapeutics Inc. Watch NEW Set a price target alert After Hours Last …

Compass Therapeutics Inc. (CMPX) stock has fallen -0.53% while the S&P 500 is higher by 0.02% as of 3:29 PM on Tuesday, Feb 14. CMPX is lower by -$0.02 from the previous closing price of $3.80 on volume of 515,663 shares. Over the past year the S&P 500 is down -5.98% while CMPX is higher by 52.42%. CMPX lost -$0.42 per share the …

The Compass Therapeutics, Inc. stock price gained 2.42% on the last trading day (Friday, 1st Dec 2023), rising from $1.65 to $1.69. During the last trading …Get free stock tools, free stock ratings, free stock charts and calculate the value of stocks to buyStock Price Forecast. The 28 analysts offering 12-month price forecasts for APA Corp (US) have a median target of 48.50, with a high estimate of 65.00 and a low estimate of 34.00. The median ...According to . 4 Wall Street analysts that have issued a 1 year CMPS price target, the average CMPS price target is $57.25, with the highest CMPS stock price forecast at $120.00 and the lowest CMPS stock price forecast at $21.00.The average Albemarle stock price prediction forecasts a potential upside of 66.63% from the current ALB share price of $121.27. What is ALB's forecast return on equity (ROE) for 2023-2026? (NYSE: ALB) forecast ROE is N/A, which is considered weak.According to the issued ratings of 4 analysts in the last year, the consensus rating for Catalyst Pharmaceuticals stock is Buy based on the current 4 buy ratings for CPRX. The average twelve-month price prediction for Catalyst Pharmaceuticals is $24.75 with a high price target of $27.00 and a low price target of $24.00.Leader in personal finance news and business forecasting. Get trusted advice on investing, retirement, taxes, saving, real estate, cars, college, insurance.4 brokers have issued twelve-month target prices for Catalyst Pharmaceuticals' stock. Their CPRX share price targets range from $24.00 to $27.00. On average, they predict the company's stock price to reach $24.75 in the next twelve months. This suggests a possible upside of 67.0% from the stock's current price.See Compass Therapeutics, Inc. (CMPX) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.Get the latest CompX International Inc. (CIX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.66.07%. Get the latest Compass Therapeutics Inc. (CMPX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment ...SCYX Stock 12 Months Forecast. $11.25. (555.98% Upside) Based on 3 Wall Street analysts offering 12 month price targets for SCYNEXIS in the last 3 months. The average price target is $11.25 with a high forecast of $15.00 and a low forecast of $7.50. The average price target represents a 555.98% change from the last price of $1.71.

Find the latest Compass Therapeutics, Inc. (CMPX) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.Complete Compass Therapeutics Inc. stock information by Barron's. View real-time CMPX stock price and news, along with industry-best analysis.The ALX Oncology Holdings Inc. stock price fell by -4.02% on the last day (Friday, 24th Nov 2023) from $9.21 to $8.84. During the last trading day the stock fluctuated 10.18% from a day low at $8.79 to a day high of $9.69. The price has risen in 6 of the last 10 days and is up by 12.76% over the past 2 weeks.Instagram:https://instagram. non traded reit listzim stock forecast 2025fidelity otc portfoliomoto vox The Fund seeks to provide long-term growth of capital. The AMCAP Fund invests primarily in common stocks of U.S. companies that have solid long-term growth records and the potential for good ... sirius xm stockshome loan with 500 credit score The average Mind Medicine stock price prediction forecasts a potential upside of 810.6% from the current MNMD share price of $3.02. What is MNMD's forecast return on equity (ROE) for 2023-2026? (NASDAQ: MNMD) forecast ROE is N/A, which is considered weak. nyse mkc Their CMPX share price targets range from $8.00 to $10.30. On average, they anticipate the company's stock price to reach $9.33 in the next year. This suggests a possible upside of 509.5% from the stock's current price. View analysts price targets for …AT&T stock has slumped in 2023, and director Stephen J. Luczo recently bought a large block of shares of the media and telecom firm. AT&T stock (ticker: T) has dropped about 12% this year, while ...